AT1 4.35% 2.4¢ atomo diagnostics limited

Ann: Access Bio receives FDA clearance for COVID-19 antibody test, page-24

  1. 1,209 Posts.
    lightbulb Created with Sketch. 646
    And if I might add a few more pending that will also shift SP:

    4. India approval for AccBio Ag test + agreed DIVOC minimum qty (prof version)
    5. India approval for NgBio-AT1 Ab test + DIVOC orders (prof version)
    5. EU CLIA waiver for NgBio-AT1 Ab test + device orders (consumer self-test version)
    6. US CLIA waiver for AccBio-AT1 Ab test + home self-test orders (consumer self-test version)

    There were other geos that mentioned many moons ago (Brazil, Philippines, HK, Taiwan etc) but haven't seen any updates)
    Last edited by FinFree101: 28/06/21
 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
(20min delay)
Last
2.4¢
Change
0.001(4.35%)
Mkt cap ! $15.34M
Open High Low Value Volume
2.3¢ 2.5¢ 2.3¢ $4.929K 214.1K

Buyers (Bids)

No. Vol. Price($)
4 440421 2.3¢
 

Sellers (Offers)

Price($) Vol. No.
2.4¢ 97565 1
View Market Depth
Last trade - 15.42pm 31/07/2024 (20 minute delay) ?
AT1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.